Recommandations relatives a la prevention des maladies cardiovasculaires en pratique clinique. Groupe de Travail Belge de Prevention des Maladies Cardiovasculaires.
De Backer, G.; De Bacquer, D.; Brohet, C.et al.
2005 • In Revue Médicale de Bruxelles, 26 (2), p. 77-87
[en] These recommendations are largely based on the Executive Summary of the "European Guidelines on Cardiovascular Disease Prevention in Clinical Practice" proposed by the "Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice". The model used to assess the overall risk was adapted for Belgium. Otherwise, very few things were changed from the Executive Summary of the European Guidelines.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
De Backer, G.
De Bacquer, D.
Brohet, C.
De Ceukelier, S.
Franck, A.
Krzentowsky, G.
Legat, P.
Pochet, J. M.
Scheen, André ; Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale
Language :
French
Title :
Recommandations relatives a la prevention des maladies cardiovasculaires en pratique clinique. Groupe de Travail Belge de Prevention des Maladies Cardiovasculaires.
Alternative titles :
[en] Recommendations for the prevention of cardiovascular diseases in clinical practice. Belgian Working Group on Prevention of Ccardiovascular Diseases
Publication date :
2005
Journal title :
Revue Médicale de Bruxelles
ISSN :
0035-3639
eISSN :
2795-8558
Publisher :
Association des Médecins Anciens Étudiants de l'Université Libre Bruxelles, Belgium
Third Joint European Societies' Task Force on cardiovascular disease prevention in clinical practice: European guidelines on CVD prevention. Eur J Cardiovasc Prev Rehab 2003; 10 (Suppl 1): S1-S78
Pyorala K, De Backer G, Graham I, Poole-Wilson P, Wood D: Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Atherosclerosis 1994; 110: 121-61
Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K: Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. Eur Heart J 1998; 19: 1434-503
The SCORE Project Group: Estimation of ten-year risk of fatal cardiovascular disease in Europe. The SCORE project. Eur Heart J 2003; 24: 987-1003
Anderson KM, Wilson PW, Odell PM, Kannel WB: An updated coronary risk profile. A statement for health professionals. Circulation 1991; 83: 356-62
Greenland P, Abrams J, Aurigemma GP et al: Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation 2000; 101: E16-E22
Urbina EM, Srinivasan SR, Tang R, Bond MG, Kieltyka L, Berenson GS: Impact of multiple coronary risk factors on the intima-media thickness of different segments of carotid artery in healthy young adults (The Bogalusa Heart Study). Am J Cardiol 2002; 90: 953-8
US Preventive Services Task Force. Guide to clinical services. Baltimore. Williams & Wilkins, 1996
Balfour D, Benowitz N, Fagerstrom K, Kunze M, Keil U: Diagnosis and treatment of nicotine dependence with emphasis on nicotine replacement therapy. A status report. Eur Heart J 2000; 21: 438-45
Long-term comprehensive care of cardiac patients. Recommendations by the Working Group on Rehabilitation of the European Society of Cardiology. Eur Heart J 1992; 13 (Suppl C): 1-45
American Association of Cardiovascular and Pulmonary: Rehabilitation. Guidelines for cardiac rehabilitation and secondary prevention programs. Human Kinetics. Champaign IL, USA, 1995
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20.536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22
A desktop guide to Type 2 diabetes mellitus. European Diabetes Policy Group 1999. Diabet Med 1999; 16: 716-30
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97
